Clinical Trial Update: Study of Melphalan and Topotecan (MT) Followed by Autologous Stem Cell Rescue in Patients With Multiple Myeloma. [Phase 1, Phase 2]

View source ↗

Summary

The study evaluated a conditioning regimen of melphalan and topotecan followed by autologous stem cell rescue in patients with multiple myeloma. It completed Ph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Melphalan (Melphalan)
• Topotecan (topotecan)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-05-23